285 related articles for article (PubMed ID: 16626815)
1. Anti-inflammatory properties of Type I interferons.
Billiau A
Antiviral Res; 2006 Sep; 71(2-3):108-16. PubMed ID: 16626815
[TBL] [Abstract][Full Text] [Related]
2. Overview of the biology of type I interferons.
Kalliolias GD; Ivashkiv LB
Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S1. PubMed ID: 20392288
[TBL] [Abstract][Full Text] [Related]
3. Interferons: the pathways of discovery. II. Immunomodulatory, in vivo and applied aspects.
Billiau A
J Clin Virol; 2007 Aug; 39(4):241-65. PubMed ID: 17580123
[TBL] [Abstract][Full Text] [Related]
4. Implications for clinical application of new developments in interferon research.
Taylor-Papadimitriou J; Balkwill FR
Biochim Biophys Acta; 1982 Sep; 695(1):49-67. PubMed ID: 6182911
[No Abstract] [Full Text] [Related]
5. [The first answer to viral infections: type I interferon].
Pichlmair A; Pollak M; Bergthaler A
Berl Munch Tierarztl Wochenschr; 2004; 117(7-8):252-65. PubMed ID: 15298051
[TBL] [Abstract][Full Text] [Related]
6. IFN-α subtypes: distinct biological activities in anti-viral therapy.
Gibbert K; Schlaak JF; Yang D; Dittmer U
Br J Pharmacol; 2013 Mar; 168(5):1048-58. PubMed ID: 23072338
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid and type 1 interferon interactions at the blood-brain barrier: relevance for drug therapies for multiple sclerosis.
Gaillard PJ; van Der Meide PH; de Boer AG; Breimer DD
Neuroreport; 2001 Jul; 12(10):2189-93. PubMed ID: 11447332
[TBL] [Abstract][Full Text] [Related]
8. Type I interferons as anti-inflammatory mediators.
Benveniste EN; Qin H
Sci STKE; 2007 Dec; 2007(416):pe70. PubMed ID: 18073382
[TBL] [Abstract][Full Text] [Related]
9. Antiviral therapy.
Smith RA; Norris FH
Adv Exp Med Biol; 1987; 209():297-304. PubMed ID: 3034000
[No Abstract] [Full Text] [Related]
10. Type I Interferon in Chronic Virus Infection and Cancer.
Snell LM; McGaha TL; Brooks DG
Trends Immunol; 2017 Aug; 38(8):542-557. PubMed ID: 28579323
[TBL] [Abstract][Full Text] [Related]
11. Short peptide type I interferon mimetics: therapeutics for experimental allergic encephalomyelitis, melanoma, and viral infections.
Ahmed CM; Johnson HM
J Interferon Cytokine Res; 2014 Oct; 34(10):802-9. PubMed ID: 24811478
[TBL] [Abstract][Full Text] [Related]
12. [Anti-viral treatment: pro or cons type I IFN?].
Whitehead P; Drouet B; Zagury D; Bensussan A
Med Sci (Paris); 2013 Oct; 29(10):836-9. PubMed ID: 24148119
[No Abstract] [Full Text] [Related]
13. Glycosylation tips the scales: Novel insights into the dual role of type-I interferons in treated HIV infection.
Raulf MK; Lepenies B
EBioMedicine; 2020 Oct; 60():103003. PubMed ID: 32980691
[No Abstract] [Full Text] [Related]
14. A brief history of the use of interferons as treatment of multiple sclerosis.
Jacobs L; Johnson KP
Arch Neurol; 1994 Dec; 51(12):1245-52. PubMed ID: 7986181
[TBL] [Abstract][Full Text] [Related]
15. Shared and Distinct Functions of Type I and Type III Interferons.
Lazear HM; Schoggins JW; Diamond MS
Immunity; 2019 Apr; 50(4):907-923. PubMed ID: 30995506
[TBL] [Abstract][Full Text] [Related]
16. Interferon-inducer antivirals: Potential candidates to combat COVID-19.
Bagheri A; Moezzi SMI; Mosaddeghi P; Nadimi Parashkouhi S; Fazel Hoseini SM; Badakhshan F; Negahdaripour M
Int Immunopharmacol; 2021 Feb; 91():107245. PubMed ID: 33348292
[TBL] [Abstract][Full Text] [Related]
17. Infergen (interferon alfacon-1).
Gastroenterol Nurs; 1998; 21(1):30-1. PubMed ID: 9555366
[No Abstract] [Full Text] [Related]
18. Identification of small molecule activators of the janus kinase/signal transducer and activator of transcription pathway using a cell-based screen.
Tai ZF; Zhang GL; Wang F
Biol Pharm Bull; 2012; 35(1):65-71. PubMed ID: 22223339
[TBL] [Abstract][Full Text] [Related]
19. Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo.
Gil MP; Salomon R; Louten J; Biron CA
Blood; 2006 Feb; 107(3):987-93. PubMed ID: 16210337
[TBL] [Abstract][Full Text] [Related]
20. [Proceedings: Current prospects in antiviral chemotherapy].
Dianzani F
Minerva Med; 1973 Nov; 64(78):4100-6. PubMed ID: 4766315
[No Abstract] [Full Text] [Related]
[Next] [New Search]
